Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

EBR Systems (ASX:EBR): What Will Its New York MedTech Presentation Highlight?

At the centre of EBR Systems' technology is the Wireless Stimulation Endocardially (WiSE) platform, a proprietary system designed to address a long-standing challenge in cardiac rhythm disease management. Conventional cardiac resynchronisation therapy, or CRT, requires leads threaded through blood vessels and positioned against the …

Sonal Goyal | 03 November 2026

Aroa Biosurgery (ASX:ARX): What Does Its CFO Appointment Mean for Expansion?

Aroa Biosurgery's products are built around its proprietary AROA ECM technology — a novel extracellular matrix bioscaffold derived from ovine forestomach. The bioscaffold is used in medical and surgical products designed to support the healing of complex wounds and soft tissue reconstruction. Unlike synthetic …

Sonal Goyal | 03 November 2026

CSL Limited (ASX:CSL): What FY26 Earnings Reveal About Its Biopharmaceutical Operations

CSL Limited (ASX:CSL) operates through CSL Behring, CSL Seqirus and CSL Vifor. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing of revenue recognition. Assessing the business therefore involves more than a headline sales figure: segment disclosures, operating …

Aditi Sarkar | 03 November 2026

Sigma Healthcare (ASX:SIG): FY26 Pharmacy Revenue and Integration Priorities

Sigma Healthcare Limited (ASX:SIG) operates through Australian pharmacy operations and international pharmacy activities. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing of revenue recognition. Assessing the business therefore involves more than a headline sales figure: segment disclosures, …

Aditi Sarkar | 03 November 2026

Fisher & Paykel Healthcare (ASX:FPH): FY26 Respiratory-Care Results Explained

Fisher & Paykel Healthcare Corporation Limited (ASX:FPH) operates through Hospital and Homecare product groups. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing of revenue recognition. Assessing the business therefore involves more than a headline sales figure: segment …

Aditi Sarkar | 03 November 2026

Pro Medicus (ASX:PME): FY26 Imaging Software Earnings and Contract Activity

Pro Medicus Limited (ASX:PME) operates through Visage Imaging products, radiology information systems and imaging workflow software. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing of revenue recognition. Assessing the business therefore involves more than a headline sales …

Aditi Sarkar | 03 November 2026

ResMed (ASX:RMD): FY26 Sleep-Health Revenue and Cash Flow in Focus

ResMed Inc. (ASX:RMD) operates through Sleep and Breathing Health products and Residential Care Software. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing of revenue recognition. Assessing the business therefore involves more than a headline sales figure: segment …

Aditi Sarkar | 03 November 2026

Ramsay Health Care (ASX:RHC): FY26 Hospital Operations and Demerger Plans

Ramsay Health Care Limited (ASX:RHC) operates through Australia, the United Kingdom and European hospital operations. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing ofRevenuerecognition. Assessing the business therefore involves more than a headline sales figure: segment disclosures, …

Aditi Sarkar | 03 November 2026

Sonic Healthcare (ASX:SHL): FY26 Pathology Revenue and Earnings Measures

Sonic Healthcare Limited (ASX:SHL) operates through laboratory medicine and healthcare diagnostic operations across multiple countries. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing of revenue recognition. Assessing the business therefore involves more than a headline sales figure: …

Aditi Sarkar | 03 November 2026

Cochlear (ASX:COH): FY26 Implant Volumes and Hearing-Care Priorities

Cochlear Limited (ASX:COH) operates through cochlear implants, Services and Acoustics. These activities carry distinct commercial characteristics, including variations in customer contracts, productSupplyrequirements and the timing of revenue recognition. Assessing the business therefore involves more than a headline sales figure: segment disclosures, operating costs and …

Aditi Sarkar | 03 November 2026
Support

Hi! How can we help you today?

Loading…